Navigation Links
Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
Date:12/21/2010

LITTLETON, Mass., Dec. 21, 2010 /PRNewswire/ --Audax Medical, Inc. (www.audaxmed.com), a privately held medical device company specializing in the development of orthobiologics, has been awarded a research and development grant through the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was established under the Patient Protection and Affordable Care Act of 2010 to support therapeutic projects that are innovative, reduce long-term healthcare costs, and/or address unmet medical needs.

The company recently announced its partnership with Brown University in the development of its core technology, Arxis™, for the regeneration of diseased bone, cartilage, and other soft tissues. The grant approval validates the strong clinical need for a cost-effective, minimally invasive solution, such as Arxis™, in orthopedic medicine.

"We are delighted to receive this recognition and funding to support the development of Arxis™. This further validates the clinical significance of our technology and the company's commitment to regenerative medicine," stated Mark A. Johanson, President and CEO of Audax.

Audax's growing technology portfolio demonstrates significant promise in multiple areas of bone and tissue preservation. The QTDP grant directly supports the company's dynamic research and development efforts in tissue regeneration, tissue reconstruction, drug delivery, and combination products. Most importantly, the funding will contribute to the company's commercialization of Arxis™, which will impact the lives of patients suffering from debilitating orthopedic conditions.

About Audax Medical, Inc.

Audax Medical, Inc. is a privately held medical device company located in Littleton, Massachusetts. The company offers innovative solutions for the treatment of degenerative bone and musculoskeletal tissue. The company's products go beyond simply stabilizing a clinical deficiency by promoting the growth of natural bone and tissue. With enhanced surgical based solutions and osteogenic biomaterial technologies, Audax offers a modern alternative to existing orthopedic therapies.  For more information visit, www.audaxmed.com


'/>"/>
SOURCE Audax Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
2. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
3. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
4. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
5. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
6. China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders
7. Nonin Medical, Inc. Announces Capnography Division Name Change; Expands Swedish Manufacturing Facility to Become Full-Franchise European Sales, Distribution and Service Center
8. CSA Medical, Inc. Announces 75th Customer
9. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
10. BlueDot Medical, Inc. Named to 2010 Inc. 500/5000
11. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):